相似文献/References:
[1]肖昂,周琼.Aflibercept治疗湿性AMD和黄斑水肿的相关研究现状[J].眼科新进展,2014,34(6):598.[doi:10.13389/j.cnki.rao.2014.0165]
[2]蒋胜群,高自清,王剑锋,等.外周血淋巴细胞DNA损伤与湿性年龄相关性黄斑变性的关系[J].眼科新进展,2018,38(8):769.[doi:10.13389/j.cnki.rao.2018.0181]
JIANG Sheng-Qun,GAO Zi-Qing,WANG Jian-Feng,et al.Relationship between the DNA damage of peripheral blood lymphocyte and wet age-related macular degeneration[J].Recent Advances in Ophthalmology,2018,38(11):769.[doi:10.13389/j.cnki.rao.2018.0181]
[3]黄玉婷,李晓洁,郑香悦,等.湿性年龄相关性黄斑变性患者抗血管内皮生长因子治疗敏感性的影响因素：基于房水细胞因子分析[J].眼科新进展,2021,41(3):240.[doi:10.13389/j.cnki.rao.2021.0050]
HUANG Yuting,LI Xiaojie,ZHENG Xiangyue,et al.Analysis of factors influencing the sensitivity of anti vascular endothelial growth factor therapy in patients with wet age-related macular degeneration based on aqueous humor cytokines[J].Recent Advances in Ophthalmology,2021,41(11):240.[doi:10.13389/j.cnki.rao.2021.0050]
[4]张敬法,赵珍珍.湿性年龄相关性黄斑变性发病机制及治疗[J].眼科新进展,2022,42(2):085.[doi:10.13389/j.cnki.rao.2022.0019]
ZHANG Jingfa,ZHAO Zhenzhen.Pathogenesis and treatment of wet age-related macular degeneration[J].Recent Advances in Ophthalmology,2022,42(11):085.[doi:10.13389/j.cnki.rao.2022.0019]
[5]肇莉莉,王萍,孙连义,等.HTRA3基因对脉络膜新生血管和M2型巨噬细胞极化的影响[J].眼科新进展,2024,44(4):275.[doi:10.13389/j.cnki.rao.2024.0054]
ZHAO Lili,WANG Ping,SUN Lianyi,et al.Effect of HtrA serine peptidase 3 gene on choroidal neovascularization and M2 macrophage polarization[J].Recent Advances in Ophthalmology,2024,44(11):275.[doi:10.13389/j.cnki.rao.2024.0054]